RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

Triple-negative breast cancer (TNBC) stands out as the most aggressive subtype within the spectrum of breast cancer. The current clinical guidelines propose treatment strategies involving cytotoxic agents like epirubicin or paclitaxel. However, the emergence of acquired resistance frequently precipi...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Fengxu Lv, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, Feifei Li
פורמט:	Article
שפה:	English
יצא לאור:	Elsevier 2024-02-01
סדרה:	Neoplasia: An International Journal for Oncology Research
נושאים:	Triple negative breast cancer Chemoresistance Cancer stem cells RUNX2 TGF-β
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S1476558624000046

פריטים דומים

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
מאת: Wentao Si, et al.
יצא לאור: (2022-11-01)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
מאת: Natalia B. Fernández, et al.
יצא לאור: (2023-01-01)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
מאת: Bradley A. Hancock, et al.
יצא לאור: (2019-08-01)

Comprehensive Analysis of RUNX and TGF-β Mediated Regulation of Immune Cell Infiltration in Breast Cancer
מאת: Liang Gao, et al.
יצא לאור: (2021-08-01)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
מאת: Guoyu Wu, et al.
יצא לאור: (2022-04-01)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
מאת: Alexander H. Chung, et al.
יצא לאור: (2019-02-01)

DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition
מאת: Jianbo Zheng, et al.
יצא לאור: (2018-04-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
מאת: Meng Wang, et al.
יצא לאור: (2021-10-01)

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
מאת: Anuradha Illendula, et al.
יצא לאור: (2016-06-01)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
מאת: Margarite D. Matossian, et al.
יצא לאור: (2019-03-01)

Data mining analysis of miR-638 and key genes interaction in cisplatin resistant triple-negative breast cancer
מאת: Adam Hermawan, et al.
יצא לאור: (2019-12-01)

The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
מאת: Adiba S. Khan, et al.
יצא לאור: (2023-02-01)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
מאת: Shen-Jun Yuan, et al.
יצא לאור: (2019-10-01)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
מאת: Ling Wang, et al.
יצא לאור: (2018-07-01)

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
מאת: Hitesh Kumar, et al.
יצא לאור: (2023-12-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
מאת: Liu C, et al.
יצא לאור: (2020-12-01)

A clinicopathologic study of triple negative breast cancer
מאת: Vandana L Gaopande, et al.
יצא לאור: (2015-01-01)

IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
מאת: Nicholas R. Hum, et al.
יצא לאור: (2022-07-01)

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
מאת: Andrew Sulaiman, et al.
יצא לאור: (2021-10-01)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
מאת: Alaa M. Ghallab, et al.
יצא לאור: (2022-04-01)

Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer
מאת: Lei Di, et al.
יצא לאור: (2019-03-01)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
מאת: Weiguang Liu, et al.
יצא לאור: (2019-09-01)

RUNX regulated immune-associated genes predicts prognosis in breast cancer
מאת: Jingyue Fu, et al.
יצא לאור: (2022-08-01)

M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer
מאת: Xi Liu, et al.
יצא לאור: (2024-02-01)

CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer
מאת: Jingchao Wang, et al.
יצא לאור: (2024-06-01)

Role of eIF4A1 in triple‐negative breast cancer stem‐like cell‐mediated drug resistance
מאת: Dayanidhi Raman, et al.
יצא לאור: (2022-12-01)

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
מאת: Ammar Said Suliman, et al.
יצא לאור: (2021-01-01)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
מאת: Yen-Dun Tony Tzeng, et al.
יצא לאור: (2018-11-01)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
מאת: Weiguang Liu, et al.
יצא לאור: (2019-07-01)

Current approaches in treatment of triple-negative breast cancer
מאת: Hanan Ahmed Wahba, et al.
יצא לאור: (2015-06-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
מאת: Mahdi Aghili, et al.
יצא לאור: (2013-08-01)

Platinum chemotherapy for early triple-negative breast cancer
מאת: Sofia RE. Mason, et al.
יצא לאור: (2024-06-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
מאת: Srijan Basu, et al.
יצא לאור: (2023-11-01)

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
מאת: Omran Saifi, et al.
יצא לאור: (2022-04-01)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
מאת: Yueh-Te Lin, et al.
יצא לאור: (2022-10-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
מאת: Elizabeth R. Berger, et al.
יצא לאור: (2021-08-01)

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
מאת: Magdalena Niedolistek, et al.
יצא לאור: (2020-04-01)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
מאת: Lisa Agnello, et al.
יצא לאור: (2023-07-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
מאת: Mohammed Amrallah A., et al.
יצא לאור: (2021-05-01)

The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer
מאת: Yi-Fen Chiang, et al.
יצא לאור: (2023-01-01)